Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia (Q39440676)

12 September 2017

title

Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia (English)

1 reference

12 September 2017

0 references

congestive heart failure

1 reference

C Stellbrink

1

1 reference

12 September 2017

A Auricchio

2

1 reference

12 September 2017

B Diem

3

1 reference

12 September 2017

O A Breithardt

4

1 reference

12 September 2017

M Kloss

5

1 reference

12 September 2017

F A Schöndube

6

1 reference

12 September 2017

H Klein

7

1 reference

12 September 2017

B J Messmer

8

1 reference

12 September 2017

P Hanrath

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

American Journal of Cardiology

12 September 2017

published in

1 reference

12 September 2017

volume

83

1 reference

12 September 2017

issue

5B

1 reference

12 September 2017

page(s)

143D-150D

1 reference

Heart failure: a growing public health problem

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

The epidemiology of heart failure: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Epidemiology of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

The epidemiology of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Arrhythmias and mortality in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Epidemiology of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Sudden death recorded during Holter monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Sudden unexpected death during ambulatory electrocardiographic monitoring. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Sudden cardiac death while wearing a Holter monitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

The effect of digoxin on mortality and morbidity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center experience)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Influence of the Implantable Cardioverter/Defibrillator on Sudden Death and Total Mortality in Patients Evaluated for Cardiac Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Implantable defibrillator therapy: does it really prolong life? How can we prove it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

When "sudden cardiac death" is not so sudden: lessons learned from the automatic implantable defibrillator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

Multisite pacing for end-stage heart failure: early experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901016-9

10.1016/S0002-9149(98)01016-9

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference